Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

HVJ-envelope vector for gene transfer into central nervous system.

Munehisa Shimamura1, Ryuichi Morishita, Masayuki Endoh

  • 1Division of Gene Therapy Science, Osaka University Graduate School of Medicine, 2-2 Yamada-oka, Suita 565-0871, Osaka, Japan.

Biochemical and Biophysical Research Communications
|December 31, 2002
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fibroblast activation protein protects the ischemic brain through regulation of post-ischemic inflammation.

Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism·2026
Same author

A RANKL-derived Peptide Inhibits RSPO3-LGR4-Wnt Signaling and Lung Adenocarcinoma in Mice.

Anticancer research·2026
Same author

Needle-Free Injection Enhances the Immunogenicity and Antitumor Efficacy of Whole-Cell Tumor Vaccines.

Vaccines·2026
Same author

Receptor activator of nuclear factor-kappa B ligand-derived microglia healing peptide 1-AcN inhibits osteoarthritis progression in mice.

Arthritis research & therapy·2025
Same author

Development of a peptide-based vaccine using a T cell epitope derived from SARS-CoV-2.

iScience·2025
Same author

Estimation of the Stages of Labor Using a Multichannel Electrohysterogram Sensor and Conditional Variational Autoencoder.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference·2025

A novel non-viral vector, HVJ-envelope (HVJ-E), shows promise for gene transfer into the central nervous system (CNS). This HVJ-E system effectively delivered reporter genes in vitro and in vivo, with enhanced activity using heparin.

Area of Science:

  • Neuroscience
  • Biotechnology
  • Gene Therapy

Background:

  • Virus vectors face challenges in gene therapy.
  • Non-viral vectors offer an alternative for gene delivery.

Purpose of the Study:

  • To evaluate the efficacy of the novel HVJ-envelope (HVJ-E) vector for gene transfer into the central nervous system (CNS).
  • To assess HVJ-E's performance in vitro and in vivo for CNS gene delivery.

Main Methods:

  • In vitro transfection of cultured rat cerebral cortex neurons and glial cells with Venus reporter gene using HVJ-E.
  • In vivo gene transfer in rat brains via direct thalamic, intraventricular, and intrathecal injections of HVJ-E carrying reporter genes (Venus, EGFP).
  • Assessment of gene expression in an ischemic stroke model (transient middle cerebral artery occlusion) and evaluation of heparin's effect on luciferase activity.

Related Experiment Videos

Main Results:

  • Successful detection of Venus reporter gene expression in cultured neurons and glial cells.
  • Demonstrated successful in vivo transfection in the rat brain across different injection routes without immunological changes.
  • Localized reporter gene expression in the injured hemisphere following ischemic stroke.
  • Significant enhancement of luciferase activity with the addition of heparin (50 U/ml).

Conclusions:

  • The HVJ-envelope vector is a feasible non-viral system for gene transfer into the CNS.
  • HVJ-E demonstrates effective in vitro and in vivo gene delivery to the brain.
  • This vector holds potential for future research and clinical applications in CNS gene therapy, especially when combined with heparin for enhanced efficacy.